Sana Biotechnology Inc
(SANA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -82,123 | -269,476 | -189,033 | -103,913 | -31,448 |
| Depreciation Amortization | 4,346 | 15,625 | 11,430 | 7,414 | 3,614 |
| Income taxes - deferred | 8,751 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -354 | 1,058 | 2,144 | 663 | 1,917 |
| Other Working Capital | -10,807 | 7,542 | 13,130 | 1,056 | -3,361 |
| Other Operating Activity | 915 | -44,799 | -51,654 | -54,407 | -48,431 |
| Operating Cash Flow | $-79,272 | $-290,050 | $-213,983 | $-149,187 | $-77,709 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,176 | -20,876 | -16,274 | -11,924 | -7,533 |
| Purchase Of Investment | -20,431 | -78,688 | -63,583 | -45,961 | -25,675 |
| Sale Of Investment | 85,334 | 310,126 | 201,991 | 148,160 | 45,753 |
| Investing Cash Flow | $62,727 | $210,562 | $122,134 | $90,275 | $12,545 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 236 | 4,913 | 3,852 | 2,231 | 652 |
| Financing Cash Flow | $236 | $4,913 | $3,852 | $2,231 | $652 |
| Beginning Cash Position | 187,273 | 261,848 | 261,848 | 261,848 | 261,848 |
| End Cash Position | 170,964 | 187,273 | 173,851 | 205,167 | 197,336 |
| Net Cash Flow | $-16,309 | $-74,575 | $-87,997 | $-56,681 | $-64,512 |
| Free Cash Flow | |||||
| Operating Cash Flow | -79,272 | -290,050 | -213,983 | -149,187 | -77,709 |
| Capital Expenditure | -2,176 | -20,876 | -16,274 | -11,924 | -7,533 |
| Free Cash Flow | -81,448 | -310,926 | -230,257 | -161,111 | -85,242 |